Psoriasis
Psoriasis – new opportunity for Oxcia
Oxcia has so far focused on treating cancer with its drug candidate OXC-101. Now the company sees a promising opportunity to...
Intervju
Lipidor's study success strengthens the company's platform
Stockholm-based Lipidor presented a clinical hit on Friday. After...